Senior doctors responsible for monitoring cancer care in England and Wales are concerned failings in NHS services are ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...

The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

For patients with advanced prostate cancer (aPC), completion of a 12-week supervised exercise regimen leads to a significant ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

The National Cancer Audit Collaborating Centre said prostate, kidney and colon cancers were the worst affected with ...

A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...